L-Arabinose

GI(Glucose = 100)

0^*0^*

Energy(kcal/100g)

—

No source on file yet.

Carbs(g/100g)

—

No source on file yet.

Sugars(g/100g)

—

No source on file yet.

Functional benefits

• Sucrase inhibition with sucrose

  Krog-Mikkelsen 2011 (AJCN): uncompetitive sucrase block in vitro; with sucrose drinks in healthy men, lower glucose/insulin peaks and higher GLP-1. Seri 1996 established selective sucrase inhibition in animals. Works only with co-ingested sucrose — not a free pass to unlimited sugar.

  Krog-Mikkelsen et al. — L-arabinose sucrase inhibition dose-response in vitro and in humans (Am J Clin Nutr) (2011)

Cited minerals can add up to +2 on Best sweetener for everyday health — see Methods.

Risks & side effects

• Osmotic GI discomfort (with sucrose)

  caution

  GI discomfort reported when taken with sucrose. Not a medical diagnosis. Scored: −7 on Everyday Health, Diabetic-friendly and Minimally processed — no symptom-free single dose on file, so the 75th percentile of rows with one (missing is not clean).

  Pasmans et al. — L-arabinose co-ingestion delays glucose absorption from sucrose (Br J Nutr) (2021)

Not medical advice. Published recipe penalties (if any) are on Methods — not a clinical severity scale.

Notes

• Works as a sucrose companion (sucrase block), not a full sugar swap. Keep real sucrose when you need caramelization — then dose arabinose against that sucrose.

  Editorial kitchen note. Human effect sizes vary by matrix (liquids clearer than complex meals).

  Seri et al. — L-Arabinose selectively inhibits intestinal sucrase (Metabolism) (1996)

• Metabolizable energy for pure L-arabinose is unsettled across sources (sometimes called noncaloric). Left empty rather than inventing kcal/100 g — Everyday stays unranked until a labeling-grade factor is on file.

  Empty-over-invention.

Notes explain what the open axis or risk labels alone can miss — not medical advice.